EU Call for Expressions of Interest: Coronavirus Research

The EU Commission has launched a call for expressions of interest for urgently needed research into the coronavirus. For this call, the Commission has mobilised €122 million from its research and innovation programme Horizon 2020. As research results are expected to be delivered quickly, deadline of this call is 11 June 2020.

The EU Commission is boosting coronavirus research and innovation by earmarking €122 million under Horizon 2020, latest addition to a range of EU-funded research and innovation actions to fight the coronavirus.

The projects funded under this call should repurpose manufacturing for rapid production of vital medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care. New research will learn from large groups of patients (cohorts) across Europe and better understanding of the behavioural and socio-economic impacts of the coronavirus epidemic could help improve treatment and prevention strategies.

The new solutions need to be available and affordable for all, in line with the principles of the Coronavirus Global Response. For this purpose, the Commission will include rapid data-sharing clauses in grant agreements, resulting from this new call, to ensure that findings and outcomes can be put to use immediately.

This call covers five areas with the following indicative budgets:
  • repurposing of manufacturing for vital medical supplies and equipment (€23 million)
  • medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
  • behavioural, social and economic impacts of the outbreak responses (€20 million)
  • pan-European COVID-19 cohorts (€20 million)
  • collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)
The deadline for submission is 11 June 2020, while the call will focus on delivering results quickly. Europe, and the world at large, urgently need innovative solutions to contain and mitigate the outbreak, and to better care for patients, survivors, vulnerable groups, frontline health care staff and their communities. This is why the Commission aims to enable research work to start as quickly as possible through shorter timelines for the preparation of expressions of interest and for their evaluation.

For more information on this call, please visit or contact catalyst Tine Schaerlaekens.